Form D · Venture Capital Fund
Clarus Lifesciences III, L.P.
Cambridge, MA · CIK 0001597143
Offering snapshot reported Jun 19, 2014 · SEC filing
- Reported sold
- $234M Offering amount: $375M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 16
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2014 | Amendment | $234,160,000 | No comparison | 16 | SEC filing |
| Feb 6, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-211426
The Total Amount Sold above includes the capital commitments of all partners of the Issuer.
A commission may be paid after the Fund closing based on a percentage of the subscriptions of certain of the Issuer's limited partners.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Snowbridge LLC | None | Sagent Advisors, LLC · CRD 129919 |
Source: Form D, filed Jun 19, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
CLARUS LIFESCIENCES III, L.P.
Investment adviser: CLARUS VENTURES, LLC
- Gross asset value
- $24.8M
- Beneficial owners
- 34
- ADV minimum commitment
- $5M
Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
DELOITTE & TOUCHE LLP
PCAOB 34
Filing source
Form ADV 2078899 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-9606722476
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Clarus Ventures Iii Gp, L.P. | Director |
| N/A Clarus Ventures Iii, Llc | Director |
| Nicholas Galakatos | Executive |
| Dennis Henner | Executive |
| Robert W. Liptak | Executive |
| Nicholas J. Simon | Executive |
| Kurt C. Wheeler | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Cambridge, MA, 02142